文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

1-磷酸鞘氨醇:内皮功能障碍与脓毒症的潜在生物标志物和治疗靶点?

Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis?
PubMed 文献 · Shock · 2017-01-01
一句话结论四项临床前观察性研究均发现脓毒症患者血清或血浆S1P水平降低,S1P可能作为内皮功能障碍与脓毒症的标志物及治疗靶点。

脓毒症是感染引起宿主反应失调导致的急性危及生命的多器官衰竭,内皮功能障碍尤其是屏障破坏导致血管通透性增加、水肿和组织氧合不足,是脓毒症发病的关键。S1P是一种信号脂质,调节血管内皮细胞通透性、炎症和凝血等病理生理过程,由于组织细胞中S1P裂解酶的活性,其在血液和淋巴中浓度高而在组织中浓度极低。近期四项临床前观察性研究检测了脓毒症患者血清或血浆S1P水平,均发现S1P水平降低且与疾病相关。本综述基于这些发现,总结了S1P调节内皮功能的相关过程,探讨了S1P作为标志物的可能性以及调控S1P水平和S1P受体激活以恢复内皮完整性、抑制炎症宿主反应和改善脓毒症器官功能的可能途径。

要点

  • 四项临床前观察性研究均发现脓毒症患者血清或血浆S1P水平降低,且与疾病相关。
  • S1P是调节血管内皮细胞通透性、炎症和凝血的重要信号脂质,内皮屏障破坏是脓毒症发病的关键环节。
  • 血液和淋巴中S1P浓度高而组织中极低,这一梯度由组织细胞中的S1P裂解酶维持。
  • 综述探讨了S1P作为脓毒症标志物的可能性,以及通过调控S1P水平和S1P受体激活来恢复内皮完整性、抑制炎症和改善器官功能的可能途径。

适用人群与场景

  • 脓毒症患者(四项临床前观察性研究检测了其血清或血浆S1P水平)

研究设计与关键结果

  • 综述汇总了四项临床前观察性研究,这些研究检测了脓毒症患者血清或血浆中的S1P水平,均发现S1P水平降低且与疾病相关。
  • 综述总结了S1P调节的内皮功能相关过程,并探讨了S1P作为标志物以及调控S1P水平和S1P受体激活以恢复内皮完整性、抑制炎症宿主反应和改善脓毒症器官功能的可能途径。

证据类型、等级与局限

  • 证据类型:综述,汇总了四项临床前观察性研究。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is an acute life-threatening multiple organ failure caused by a dysregulated host response to infection. Endothelial dysfunction, particularly barrier disruption leading to increased vascular permeability, edema, and insufficient tissue oxygenation, is critical to sepsis pathogenesis. Sphingosine-1-phosphate (S1P) is a signaling lipid that regulates important pathophysiological processes including vascular endothelial cell permeability, inflammation, and coagulation. It is present at high concentrations in blood and lymph and at very low concentrations in tissues due to the activity of the S1P-degrading enzyme S1P-lyase in tissue cells. Recently, four preclinical observational studies determined S1P levels in serum or plasma of sepsis patients, and all found reduced S1P levels associated with the disease. Based on these findings, this review summarizes S1P-regulated processes pertaining to endothelial functions, discusses the possible use of S1P as a marker and possibilities how to manipulate S1P levels and S1P receptor activation to restore endothelial integrity, dampens the inflammatory host response, and improves organ function in sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Winkler MS, Nierhaus A, Poppe A, et al. Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis? Shock. 2017. PMID: 27922551. doi:10.1097/SHK.0000000000000814

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。